中文
Stockinsky

Sector leaders · Company list

ADC Drugs

Covers target discovery, linker and conjugation technology and manufacturing for antibody-drug conjugates, a closely watched field in innovative-drug out-licensing and the upgrading of cancer therapy.

Why these companies

Selection basis

Representative companies are selected from 2025 clinical progress, overseas licensing deals and capacity plans for domestic antibody-drug conjugates. Updated 2026-09-29 · unordered list

Representative companies

ADC Drugs leader list

5 companies
A-shares

Hengrui Pharmaceuticals

A comprehensive leader in innovative drugs and antibody-drug conjugates

600276 Public report available
Hong Kong stocks

CSPC Pharmaceutical

Representative platform company in innovative drugs and antibody-drug conjugates

01093 Report not generated

A standard report for a new stock is free for the first generation. Professional valuation is paid and uses one credit. Existing public reports are free to view.

Sources

Industry and company sources

This page is a research directory. “Representative leader” is not an official designation, a return forecast or trading advice. Valuations and reports may contain errors or outdated information; verify against company filings and authoritative sources.